IGF-1 LR3 is an extended-action regulatory peptide associated with supporting cellular activity, recovery processes, and functional adaptation of body tissues. Due to its stable mechanism of action, the product is considered an element of modern regenerative performance, metabolic recovery, and comprehensive physical support programs.
Within recovery and functional protocols, IGF-1 LR3 is used to support regenerative processes, adaptation to physical loads, and the body’s metabolic activity. A gradual format of use allows individual characteristics of physiological response and recovery potential to be taken into account.
Indicative scheme for IGF-1 LR3:
| Period | Dose |
|---|---|
| Weeks 1–2 | 20–40 mcg |
| Weeks 3–4 | 40–60 mcg |
| Weeks 5–8 | 60–100 mcg |
| From week 9 | Individually according to the program |
The usage regimen and dosage selection are determined individually, taking into account the program goals, the level of physical activity, and the characteristics of the body’s metabolic adaptation. Before use, it is recommended to review the product information and consult a specialist.
There are no reviews for this product, be the first to leave your review.
No questions about this product, be the first and ask your question.